Status:
COMPLETED
Women and Risk of Type 2 Diabetes
Lead Sponsor:
University of Oslo
Collaborating Sponsors:
Norwegian Diabetes Association
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
FEMALE
27-60 years
Brief Summary
This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related ...
Detailed Description
The STORK-Groruddalen is a cohort study of 823 pregnant women. Participation rate was high due to facilitation for ethnic minorities and data collection at the local Health Centres, set up to study et...
Eligibility Criteria
Inclusion
- Previous participants in the STORK G study still living in Norway
Exclusion
- Moved out of Norway
Key Trial Info
Start Date :
August 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
383 Patients enrolled
Trial Details
Trial ID
NCT03870724
Start Date
August 27 2019
End Date
March 30 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oslo, Faculty of Medicine, Institute of Health and Society
Oslo, Norway, 0316 Oslo